FDA leaders detail reorg plans, say 1,500 ORA staff will be reassigned

Regulatory NewsRegulatory NewsBiologics/ biosimilars/ vaccinesDiagnostics/IVDsGenericsMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited States